Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$2.86 - $4.97 $108,680 - $188,860
38,000 New
38,000 $108,000
Q2 2022

Aug 16, 2022

SELL
$3.21 - $7.86 $45,488 - $111,384
-14,171 Reduced 39.18%
22,000 $71,000
Q1 2022

May 12, 2022

BUY
$4.65 - $7.4 $168,195 - $267,665
36,171 New
36,171 $255,000

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $475M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Josh Arnold Investment Consultant, LLC Portfolio

Follow Josh Arnold Investment Consultant, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Josh Arnold Investment Consultant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Josh Arnold Investment Consultant, LLC with notifications on news.